A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Breast Reconstruction Decision Aid (RECONJOINT)
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether a larger study of RECONJOINT, a tool to help people decide about breast reconstruction, can be done. It is for adults considering surgery to rebuild a breast after breast removal, and doctors who provide this care.
The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Patients and focus group members must be age 18 or older.
- Patients and focus group members must have a confirmed inherited risk of breast cancer, cancer inside the breast milk ducts, or cancer that has grown into nearby tissue.
- Patients and focus group members must be considering surgery to rebuild a breast after breast removal.
- Patients in the trial must have a visit scheduled with a plastic surgery provider.
- Doctors in the trial must have spent over half of their surgery cases in the past calendar year on breast reconstruction.
Who can't join
- Patients and focus group members cannot join if they are not considering breast reconstruction after breast removal.
- Patients in the trial cannot join if their breast cancer has come back or spread to distant parts of the body.
- Male patients cannot join the trial.
- Doctors cannot join if breast reconstruction makes up less than half of their care.
- People in any group cannot join if they are not proficient in English.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Participant Inclusion Criteria Focus Group Participants * A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record * ≥18 years old * Considering post-mastectomy breast reconstruction RCT Participants (Patients) * A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record * ≥18 years old * Considering post-mastectomy breast reconstruction * Have an appointment scheduled for consultation with a plastic surgery provider RCT Participants (Physicians) * Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery. Participant Exclusion Criteria Focus Group Participants * Not considering post-mastectomy breast reconstruction * Non-English proficiency RCT Participants (Patients) * Not considering postmastectomy breast reconstruction * Recurrent or metastatic breast cancer * Male sex * Non-English proficiency RCT Participants (Physicians) * Does not provide breast reconstruction care at least 50% of the time * Non-English proficiency
Study sites (9)
NC
- Duke Cancer Institute (Data collection only) · Durham, NC 27710Brett Phillips · Study contact · 888-275-3853More trials in Durham
- Duke Cancer Institute (Data collection only) · Durham, NC 27710Brett Phillips · Study contact · 888-275-3853More trials in Durham
NJ
- Memorial Sloan Kettering Basking Ridge · Basking Ridge, NJ 07920Evan Matros, MD · Study contact · 646-608-8044More trials in Basking Ridge
- Memorial Sloan Kettering Monmouth · Middletown, NJ 07748Evan Matros, MD · Study contact · 646-608-8044More trials in Middletown
- Memorial Sloan Kettering Bergen · Montvale, NJ 07645Evan Matros, MD · Study contact · 646-608-8044More trials in Montvale
NY
- Memorial Sloan Kettering Commack · Commack, NY 11725Evan Matros, MD · Study contact · 646-608-8044More trials in Commack
- Memorial Sloan Kettering Westchester · Harrison, NY 10604Evan Matros, MD · Study contact · 646-608-8044More trials in Harrison
- Memorial Sloan Kettering Cancer Center · New York, NY 10065Evan Matros, MD · Study contact · 646-608-8044More trials in New York
- Memorial Sloan Kettering Nassau · Rockville Centre, NY 11553Evan Matros, MD · Study contact · 646-608-8044More trials in Rockville Centre